Additionally, epithelial cells with elevated CDCA4 expression in tumor tissues are associated with radiotherapy resistance in CRC patients, suggesting that CDCA4 could serve as a critical therapeutic target. The gene discussed is CDCA4; the disease is colorectal carcinoma.